Drug Profile
Tretinoin - Lypro Biosciences
Alternative Names: All trans retinoic acid - Lypro Biosciences; ATRA-ND; ATRA-tNDLatest Information Update: 31 Oct 2021
Price :
$50
*
At a glance
- Originator Lypro Biosciences
- Class Antiacnes; Antineoplastics; Cyclohexenes; Keratolytics; Retinoids; Small molecules
- Mechanism of Action Protein synthesis inhibitors; Retinoic acid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Mantle-cell lymphoma
Most Recent Events
- 28 Jul 2018 No recent reports of development identified for research development in Mantle-cell-lymphoma in USA
- 01 Aug 2016 Chemical structure information added
- 26 Jul 2016 Early research is ongoing in USA